The foreseeability of real anti-aging medicine: Focusing the debate

Experimental Gerontology

Volumn 38, Issue 9, 2003, Pages 927-934

  De Grey, Aubrey D N J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anti aging medicine; Biotechnology; Evolution; Policy implications; Retarding aging; Reversing aging

Indexed keywords

AGING; BIOTECHNOLOGY; EVOLUTION; GERONTOLOGICAL RESEARCH; LIFESPAN; PRIORITY JOURNAL; REVIEW;

EID: 0041883773     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(03)00155-4     Document Type: Note

References (37)

1. Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found. Symp. 231:2000;7-15.
2. Carnes B.A., Olshansky S.J., Grahn D. Biological evidence for limits to the duration of life. Biogerontology. 4:2003;31-45.
3. de Grey A.D.N.J. More on mitochondria and senescence - reply. BioEssays. 19:1997;534.
4. de Grey A.D.N.J. Mitochondrial gene therapy: an arena for the biomedical use of inteins. Trends Biotechnol. 18:2000;394-399.
5. de Grey A.D.N.J. Gerontologists and the media: the dangers of over-pessimism. Biogerontology. 1:2000;369-370.
6. de Grey A.D.N.J. Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome. Trends Biotechnol. 20:2002;452-455.
7. de Grey, A.D.N.J., 2003. An engineer's approach to the development of real anti-aging medicine. Science's SAGE KE 2, http://sageke.sciencemag.org/cgi/content/full/sageke;2003/1/vp1 .
8. de Grey A.D.N.J. Challenging but essential targets for genuine anti-ageing drugs. Expert Opin. Ther. Target. 7:(1):2003;1-5.
9. de Grey A.D.N.J. Fear of misrepresentation cannot justify silence about foreseeable life-extension biotechnology. BioEssays. 25:2003;94-95.
10. de Grey A.D.N.J., Ames B.N., Andersen J.K., Bartke A., Campisi J., Heward C.B., McCarter R.J.M., Stock G. Time to talk SENS: critiquing the immutability of human aging. Ann. NY Acad. Sci. 959:2002;452-462.
11. de Grey A.D.N.J., Baynes J.W., Berd D., Heward C.B., Pawelec G., Stock G. Is human aging still mysterious enough to be left only to scientists? BioEssays. 24:2002;667-676.
12. de Grey A.D.N.J., Gavrilov L., Olshansky S.J., Coles L.S., Cutler R.G., Fossel M., Harman S.M. Antiaging technology and pseudoscience. Science. 296:2002;656.
13. Dennett D.C. Elbow room: the varieties of free will worth wanting. 1984;MIT Press, Cambridge, MA.
14. Edney E.B., Gill R.W. Evolution of senescence and specific longevity. Nature. 220:1967;281-282.
15. Epstein S.S., Ashford N.A., Blackwelder B., Castleman B., Cohen G., Goldsmith E., Mazzocchi A., Young Q.D. The crisis in U.S. and international cancer policy. Int. J. Health Serv. 32:2002;669-707.
16. Gershon D. More on mitochondria and senescence. BioEssays. 19:1997;533-534.
17. Harris J. Essays on science and society: intimations of immortality. Science. 288:2000;59.
18. Hayflick L. How and why we age. 1994;Ballantine Books, New York.
19. Hayflick L. The future of ageing. Nature. 408:2000;267-269.
20. Himsworth R.L., Goldacre M.J. Does time spent in hospital in the final 15 years of life increase with age at death? A population based study. BMJ. 319:1999;1338-1339.
21. Hodes, R.J., 2001. National Institute on Aging, Fiscal Year 2002 Director's Statement. http://www.nia.nih.gov/about/legislation/fy2002/testimony/ls/ds.htm .
22. Holliday R. Understanding ageing. 1995;Cambridge University Press, Cambridge, UK.
23. Kaiser J. War on cancer. NCI goal aims for cancer victory by 2015. Science. 299:2003;1297-1298.
24. Keyfitz N. Population growth, development and the environment. Population Stud. 50:1996;335-359.
25. Kirkwood T.B.L. Evolution of ageing. Nature. 270:1977;301-304.
26. Le Bourg E. Gerontologists and the media in a time of gerontology expansion. Biogerontology. 1:2000;89-92.
27. Le Bourg E. A public debate about the feasibility of reversing human ageing could be detrimental. BioEssays. 25:2003;93-94.
28. Lighthill J. Artificial intelligence, a general survey. Lighthill J., Sutherland N.S., Needham R.M., Longuet-Higgins H.C., Michie D. Artificial Intelligence: A Paper Symposium. 1973;1-21 Science Research Council of Greast Britain, London, UK.
29. Manton K.G., Corder L., Stallard E. Chronic disability trends in elderly United States populations: 1982-1994. Proc. Natl. Acad. Sci. USA. 94:1997;2593-2598.
30. Martinez D. Mortality patterns suggest lack of senescence in hydra. Exp. Gerontol. 33:1998;217-225.
31. Menzies R.A., Gold P.H. The turnover of mitochondria in a variety of tissues in young adult and aged rats. J. Biol. Chem. 246:1971;2425-2429.
32. Miller R.A. Extending life: scientific prospects and political obstacles. Milbank Q. 80:2002;155-174.
33. National Institutes of Health, 2001. NIH Almanac 2002. NIH Publications No. 01-5; http://www.nih.gov/about/almanac/appropriations/index.htm .
34. Olshansky S.J., Hayflick L., Carnes B.A. Position statement on human aging. J. Gerontol. A Biol. Sci. Med. Sci. 57:2002;B292-B297.
35. Olshansky S.J., Rudberg M.A., Carnes B.A., Cassel C., Brody J. Trading off longer life for worsening health: the expansion of morbidity hypothesis. J. Aging Health. 3:1991;194-216.
36. Schwartz M. The life and works of Louis Pasteur. J. Appl. Microbiol. 91:2001;597-601.
37. United Nations, 2001. World population prospects, 2000 revision. http://www.un.org/esa/population/publications/wpp2000/.